Oncologists

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Mar / 2026

March 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

« Feb

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Yelena Janjigian and Norah Lewin Join NBC's Saturday TODAY to Discuss Cycle for Survival's 20th Anniversary

Yelena Janjigian and Norah Lewin Join NBC's Saturday TODAY to Discuss Cycle for Survival's 20th Anniversary

Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges

Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges

The One Vaccine That Could Save a Generation of Indian Women

The One Vaccine That Could Save a Generation of Indian Women

SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer

SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer

Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group

Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group

$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance

$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance

CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance

CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance

Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed

Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed

Oncologists

Ain Shams University
Al-Mehwar Hospital
Barts Cancer Centre
BC Cancer Centre for the North
Cairo University
CEBROM Medicina Oncológica
Centro Hospitalar Universitário do Algarve (CHUA)
Centro Paulista de Oncologia
Clinique d'Oncologie 16 Novembre
Clinique d’Oncologie du 16 Novembre
CommonSpirit Health
Dana-Farber Cancer Institute
Dasa Oncologia
David Geffen School of Medicine at UCLA
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Enterome
European Institute of Oncology
First Ladies Against Cancer (FLAC)
Frattamaggiore Hospital
Genolier Cancer Center
Ghent University Hospital
Gustave Roussy
Hacettepe University
Hadassah Medical Moscow
Harvard Medical School
Hassan II University Hospital
HCG Cancer Centre
Hospital Brasília
Hospital Israelita Albert Einstein
Hospital Sant Joan de Déu Barcelona
Hospital Sírio-Libanês in São Paulo
Humanitas University
Indiana University Health
Institut Curie/Saint-Cloud
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Johns Hopkins University
Jonsson Comprehensive Cancer Center
Karmanos Cancer Institute
Khwaja Yunus Ali Medical College & Hospital
King Hussein Cancer Center (KHCC)
Massachusetts General Hospital Cancer Center
Mayo Clinic
McGill University Health Centre
MD Anderson Cancer Center
Médio Ave Local Health Unit
Memorial Sloan Kettering Cancer Center
Montefiore Einstein Comprehensive Cancer Center
N.N. Blokhin National Medical Research Center of Oncology
National Cancer Centre Singapore
Norton Healthcare
Pediatric Cancer Center Barcelona
Peter MacCallum Cancer Centre
Princess Maxima Center for Pediatric Oncology
Sarvodaya Cancer Institute
St. Elizabeth Healthcare – Yung Family Cancer Center
Stanford Medicine
The Children’s Hospital Lahore
The Chinese University of Hong Kong
The David Geffen School of Medicine at UCLA
The Division of Quality of Life and Pediatric Palliative Care at Stanford University
The Faculty of Medicine, University of Belgrade
The Kinghorn Cancer Centre
The Post Graduate Institute of Child Health
The Sylvester Comprehensive Cancer Center at the University of Miami
The Universitätsklinik für Hämatologie
The University Hospital of Bologna IRCCS
The University of Chicago Medicine
The University of Cincinnati Cancer Center
Townsville University Hospital
Unidade Local de Saúde do Algarve
Université Paris-Saclay
University Children’s Hospital Freiburg,
University Hospital in Krakow
University of Arizona Cancer Center
University of British Columbia
University of California San Diego
University of Colorado Anschutz Medical Campus
University of Leipzig Medical Center
University of Leuven (KULeuven)
University of Michigan
VITAZ
Yale School of Medicine
Yeolyan Hematology and Oncology Center

Breast Oncology
Gastrointestinal Oncology
Genitourinary Oncology
Geriatric Oncology
Leukemia
Lymphoma
Pediatric Oncology
Precision Oncology
Solid Tumors
Supportive Care
Survivorship
Translational Oncology
Тhoracic oncology

Global Health Advocate
Hematologist
Medical Oncologist
Oncologist
Palliative Care Specialist
Pediatric Hematology & Oncology
Pediatric Oncologist
Radiation Oncologist
Research Scientist
Surgical Oncologist
Urologic Oncology

Eric Van Cutsem

Eric Van Cutsem

Leuven, Belgium

Jay M. Lee

Jay M. Lee

Los Angeles, USA

Khushali Jhaveri

Indianapolis, USA

Raffaele Addeo

Raffaele Addeo

Daniel Olson

Daniel Olson

Francesco Massari

Francesco Massari

Douglas Flora

Douglas Flora

Aparna Parikh

Aparna Parikh

Rachna Shroff

Rachna Shroff

Gregory Kalemkerian

Gregory Kalemkerian

Hagop-Kantarjian

Hagop Kantarjian

Florian Lordick

Florian Lordick

Leipzig, Germany

LIdia Schapira

Lidia Schapira

Sarkis Meterissian

Sarkis Meterissian

Montreal, Canada

Rob Pieters

Rob Pieters

Utrecht, Netherlands

Matti Aapro

Matti Aapro

Genolier, Switzerland

Giuseppe Curigliano

Giuseppe Curigliano

Yelena Janjigian

Yelena Janjigian

Not found

3

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials prostate cancer FDA AACR UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Robert Orlowski Myeloma NCI Vivek Subbiah Myeloma Paper of the Day National Cancer Institute American Society of Clinical Oncology Pancreatic Cancer Paolo Tarantino healthcare AI radiation oncology cervical cancer IASLC WHO ASCO25 Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu multiple myeloma

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}